A Golden Rice Opportunity

Finally, after 12 years of delay caused by opponents of genetically modified foods, so-called “golden rice” with vitamin A will be grown in the Philippines. Over those 12 years, about eight million children worldwide died from vitamin A deficiency, but the resistance to GM crops continues unabated.

SÃO PAULO – Finally, after 12 years of delay caused by opponents of genetically modified (GM) foods, so-called “golden rice” with vitamin A will be grown in the Philippines. Over those 12 years, about eight million children worldwide died from vitamin A deficiency. Are anti-GM advocates not partly responsible?

Golden rice is the most prominent example in the global controversy over GM foods, which pits a technology with some risks but incredible potential against the resistance of feel-good campaigning. Three billion people depend on rice as their staple food, with 10% at risk for vitamin A deficiency, which, according to the World Health Organization, causes 250,000-500,000 children to go blind each year. Of these, half die within a year. A study from the British medical journal The Lancet estimates that, in total, vitamin A deficiency kills 668,000 children under the age of five each year.

Yet, despite the cost in human lives, anti-GM campaigners – from Greenpeace to Naomi Klein – have derided efforts to use golden rice to avoid vitamin A deficiency. In India, Vandana Shiva, an environmental activist and adviser to the government, called golden rice “a hoax” that is “creating hunger and malnutrition, not solving it.”

To continue reading, please log in or enter your email address.

To access our archive, please log in or register now and read two articles from our archive every month for free. For unlimited access to our archive, as well as to the unrivaled analysis of PS On Point, subscribe now.

required

By proceeding, you agree to our Terms of Service and Privacy Policy, which describes the personal data we collect and how we use it.

Log in

http://prosyn.org/ZKBrebt;

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated cookie policy and privacy policy.